Notre actualité
In the context of NanoStem Project, a Marie-Curie Innovative Training Network project funded by the European Union’s Horizon 2020, and in collaboration with HCS Pharma, Elisa L.J. Moya defensed successfully her PhD the 15th December 2021 in Université d’Artois (Lens, France) about the miniaturization and automation of a well-established human Read more…
About 90% of drug candidates fail in clinical trials, for efficacy- and toxicity-related reasons, which often involve the Central Nervous System (CNS). This high failure rate highlights a lack of relevance in experimental models used upstream, including human in vitro models. Indeed, they do not take into account the complexity Read more…
2022 is beginning, but 2021 ended in the most beautiful way… with Véronique De Conto‘s PhD defense. She successfully defended her PhD thesis about the importance of the microenvironment in cerebral in vitro models for phenotypic screening. We had the privilege to maintain the PhD defense on-site, even if one member Read more…
Launched in 2016, the adventure is coming to an end after 5 years of work carried out within the RHU CHOPIN (CHOlesterol Personalized INnovation), and with a strong collaboration between HCS Pharma and l’Institut du thorax. This collaborative project of national scope was led by Professor Bertrand Cariou, director of Read more…
We are very please to announce a marketing alliance with the Japanese company JVCKENWOOD Corporation in order to distribute all BIOMIMESYS® products in Japan and some parts of Asia. We are honored to work with a such famous brand. JVCKENWOOD will begin developing sales of HCS Pharma products through collaboration Read more…
After several awards and labels in the field of deeptech (Invest Horizon, Hello Tomorrow), we are happy to enter the deeptech community of Bpifrance (Banque Publique d’Investissement France). This community (on the platform lesdeeptech.fr in french) is a “link generator” between many stakeholders. First, it allows deeptech companies to share Read more…
During the last BIO Asia-Taiwan event HCS Pharma was awarded by the National Health Research Institute (NHRI) as a key company (關鍵新創) in the “Partnering and Medical Innovation” category (攜手同行暨創醫獎) for the BIOMIMESYS® technology. BIOMIMESYS® was recognized as a groundbreaking technology, allowing to reproduce any type of healthy or cancerous Read more…
A l’occasion du Salon “Made in France” de Paris, nous sommes très heureux de vous rappeler que la technologie BIOMIMESYS® est une deeptech française reconnue au niveau européen et dont toute la R&D et la production se déroule sur le territoire national. Nous sommes fiers de faire rayonner le savoir-faire Read more…
We are glad to inform you that we will organise the next webinar about BIOMIMESYS Oncology hydroscaffold and its applications in cancer research on the 23rd and 25th of November. Our project leader Elodie Vandenhaute will talk to you about how to use BIOMIMESYS for modelling cancer tissues and responses Read more…
We are very happy to be present at BIO Asia-Taiwan this week as a member of the National Health Research Institutes (NHRI) Technology Transfer & Incubation Center (TTIC). You can find us on the NHRI’s booth, 4th floor R332. We will present our products BIOMIMESYS® and our last developments. If Read more…
This year, InnaSCo and Frontinov propose a joint scientific meeting dealing with inflammation, including presentations of prestigious speakers. This meeting will take place next week as a 2-day webinar, on the 20th and 21st October. The first day will be dedicated to quantitative biology approaches for exploration of inflammatory responses. This part of the Read more…
As you might know, October is the Breast Cancer Awareness Month, an annual campaign to raise awareness about the impact of breast cancer. Research is the key tool to fight this disease and we are very happy to collaborate with amazing research teams in this fight. Since last year, our Read more…
This week we will present at the thematic school “From 3D culture to the organoid: multidisciplinary research” organised by the Institute of Biological Sciences of CNRS (France) in Strasbourg. Study director Méryl Roudaut will talk about the generation of functional human liver organoids using hiPSC and our innovative 3D cell Read more…
Want to try 3D cell culture in your lab? Why not testing BIOMIMESYS®, our 3D cell culture system made in France? Please feel free to contact us at hello@biomimesys.com (or with this form) for any question… We will answer in french, or in english 🙂
We are very please to participate to the online Investment Forum of EUTECH, beginning august 24th. You will find us on booth 103 and we will be available for online meeting. As we are in development both in Asia, in USA and in Europe we are looking for investors to Read more…
Summer is alway a good time to improve our services. Then we are very happy to introduce our updated Skin Pigmentation and Oxidative Stress services. Pigmentation is particularly regulated at the cellular level by melanocytes synthesizing melanin within melanosomes, which can be produced in varying sizes, numbers, and densities. In order to evaluate Read more…
We are pleased to announce that HCS Pharma secured 20 Million EUR capital commitment from GEM group following the public listing of the company shares on a European stock exchange. We are under the IPO process that we will finalize in the next coming months. The proceeds of IPO with Read more…
We were glad to welcome Roberta Bilardo for a 2 month-secondment in HCS Pharma in the frame of Nanostem project (Developing NANOmaterials for neural STEM cells drug delivery). She is working as a Marie Curie Fellow Early Stage Researcher in Prof Resmini’s research group at the School of Biological and Read more…
Today is the opening of the virtual part of 2021 BIO-Asia Taiwan and we are happy to welcome you on our booth (R332) to present our latest innovations with BIOMIMESYS® for liver organoids. This event is organized by Taiwan Bio Industry Organization and Chan Chao International Co. It gathers over Read more…
As part of their engineering studies at ISEN Lille for a master’s degree specialized in Bionanotechnologies, Robin and Orégane arrived in HCS Pharma in May 2021 for a 4-month internship. Their work in HCS Pharma follows a student project during which they designed and computationally simulated a microfluidic device capable Read more…
We are really pleased to announce that we have officially created a representative office in Taïwan (company 仿生培養技術中心 ID number 90729614) which is directed by our partner, Joseph Chou 周肇隆 ジョーゼフ・チョウ, member of our advisory board. Thanks to Joseph and Professor Szecheng J. Lo, member of our scientific advisory board, all Read more…
Since the beginning of this year we have created four webinars to present our BIOMIMESYS® technology and practical uses. We have chosen to focus on the scientific side of our innovation by presenting results in drug discovery or dermocosmetology domains. Theses four webinars are available on our support page (with many Read more…
Maybe you are looking for a solution for your 3D cell culture and, after a Google or a Pubmed search, you find us and the BIOMIMESYS® technology. Or, you saw a publication or a poster about our research and you came here to better know what we do. Whatever your Read more…